Form EFFECT Esperion Therapeutics,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | July 15, 2026 |
| Accession Number: | 0001104659-26-083007 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Comdata Launches Pay Codes, Advancing Its Longstanding Commitment to Protecting Fleets and Drivers
- OktoRocket Benchmark Data Points to Rising Labor Rates as a Signal of Consumer Spending Pressure, Alongside a Costly Staffing Gap in the Service Industry
- Netrio CEO Mark Clayman Named to Channel Insider's 2026 AI Leaders in the Channel List
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
